XNYS · Healthcare · Drug Manufacturers - Specialty & Generic
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | 1.46 | 1.53 | +4.79% | $2.38B | ✅ Beat | -0.02% | -5.71% | — |
| 2026-08-06 | Q1 2027 | 0.87 | 0.98 | +12.64% | $265.7M | ✅ Beat | -0.02% | -5.71% | — |
| 2026-05-13 |
| Q4 2026 |
| 1.40 |
| 1.23 |
| -12.14% |
| $281.6M |
| ❌ Miss |
| -8.15% |
| -8.92% |
| -7.70% |
| 2026-05-07 | Q1 2026 | 0.85 | 0.83 | -2.35% | $2.05B | ❌ Miss | -3.68% | -15.86% | -13.57% |
| 2026-03-19 | Q4 2025 | 1.35 | 1.29 | -4.44% | $1.90B | ❌ Miss | +0.08% | +0.53% | -3.21% |
| 2026-02-05 | Q3 2026 | 1.16 | 1.14 | -1.72% | $283.4M | ❌ Miss | -4.39% | +2.15% | +2.50% |
| 2025-02-06 | Q3 2025 | 1.16 | 1.22 | +5.17% | $290.3M | ✅ Beat | -0.40% | -1.91% | -0.56% |
| 2024-11-07 | Q2 2025 | 1.08 | 1.09 | +0.93% | $283.8M | ✅ Beat | +0.35% | +3.37% | +3.98% |
Showing last 8 quarters.